P. West

Current Clinical Trials of Epothilone B Analog (BMS-247550)

B. Cheson, A. Colevas, P. West, 2001 .

Investigational Drug Steering Committee Trial Design Task Force of the National Cancer Institute Therapeutics : Consensus Recommendations from the Clinical The Design of Phase II Clinical Trials Testing Cancer

D. Berry, J. Crowley, S. Groshen, 2010 .

Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

S. Groshen, C. Tangen, C. Drake, 2016, Bladder cancer.

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management

M. Atkins, M. Callahan, A. Hansen, 2018, JNCI cancer spectrum.

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Susan Groshen, Larry Rubinstein, Lesley Seymour, 2010, Clinical Cancer Research.

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

D. Berry, J. Crowley, S. Groshen, 2010, Clinical Cancer Research.